Clickability tracking pixel

COVID-19: Pfizer Gets $1.95 Billion to Produce Coronavirus Vaccine by Year’s End

Good, fast or cheap ... which do you want?

by Eric Holdeman / July 22, 2020

The Trump administration is straining to have some "good coronavirus news" to announce. Their best hope at this point in the disease is the development of a vaccine -- but it likely won't be ready for prime time before the November presidential election.

There were other opportunities in the past:

  • Test kits -- nope
  • Testing -- nope
  • Personal Protective Equipment (PPE) -- still failing
  • Public information messaging on the disease -- double nope-nope
  • Moral leadership and leading by example -- nope
  • Consistent and coordinated messaging from the administration overall -- nope
  • Opening up America safely -- nope
  • Recommending safe anti-virals -- nope
  • Did I miss anything?

The New York Times highlighted the latest gambit, Pfizer Gets $1.95 Billion to Produce Coronavirus Vaccine by Year’s End.

I believe the headline from the White House will be something like, "The United States Has Vaccine for Every Person Needing One." Which could be true, but that Federal Drug Administration (FDA) stamp of approval has to be attached to the drug. If you recall the doctor's oath that includes "Do no harm" as a center piece. 

Maybe we can get a good vaccine that is "good" and "fast," but certainly not cheap. I want a vaccine too, but the person telling me we have one, needs to be one who has proven himself trustworthy, honest, forthright, concerned about me and not just himself. 

Dr. Fauci perhaps?

 

Platforms & Programs